SillaJen's "SJ-600" Preclinical Study Paper Accepted by American Immuno-Oncology Society Journal

[Asia Economy Reporter Lee Gwan-ju] On the 16th, SillaJen announced that a paper containing the preclinical research results of the 'SJ-600' series, being developed as a next-generation oncolytic virus platform, was accepted by the official journal of the Society for Immunotherapy of Cancer (SITC), the Journal for ImmunoTherapy of Cancer (JITC).

Medical and pharmaceutical research and development company Sillajen held a corporate briefing session at the Seoul Press Center on the 13th of last month, where they discussed the current status of research and development and future plans. Executive Director Park Sang-geun is explaining the clinical status and plans for the next-generation anticancer virus. Photo by Heo Young-han younghan@

The paper to be published this time is a study on the preclinical research of the SJ-600 series conducted by SillaJen and the research team from Seoul National University College of Medicine. In clinical studies, the new oncolytic viruses including SJ-607 showed effective tumor growth inhibition after intravenous administration across various cancer types compared to existing oncolytic viruses. This overcomes the limitations of existing oncolytic viruses that are directly injected into tumors, and it is expected to expand indications to various solid tumors as well as deep-seated cancers.

JITC is the official journal of the Society for Immunotherapy of Cancer, with an impact factor (IF) of 12.469, recognized as a highly prestigious top-tier journal. Founded in 1984, the Society for Immunotherapy of Cancer is the most authoritative society in the field of immuno-oncology, with over 4,600 researchers and clinicians from 63 countries worldwide.

A SillaJen official stated, "With the commitment of the largest shareholder M2N and Chairman Seo Hong-min, we have actively invested human and material resources in the development of the SJ-600 series," adding, "We are very encouraged that a paper containing the research results of the SJ-600 series has been accepted by a globally prestigious journal." The paper will be disclosed through the journal and the official website in the future.

This content was produced with the assistance of AI translation services.